Dlx5 homedomain / DNA complex; structure, binding and
effect of mutations related to split - hand and foot malformation syndrome.
Not exact matches
His lab is now investigating what happens in the earliest stages
of the development
of mice with the autism -
related Shank3
mutation, and whether any
of those
effects can be reversed either during development or later in life.
Recently, his lab used induced pluripotent stem (iPS) cells — adult cells made to act like embryonic stem cells — made from skin cells
of patients carrying apoE4, or other
mutations related to Alzheimer's, to study their
effects on the development, survival, and degeneration
of human neurons.
The
effects of disrupting the «silent» genes revealed in these studies may be masked by the activity
of related genes, or because their
mutations produce defects that are not readily apparent in casual observation under normal laboratory conditions.
To study the
effects of LRO -
related gene
mutations, Dr. Huizing is performing fluorescent protein expression studies using patients» cells in order to examine defective intracellular trafficking.
However, any data obtained from iPS is a combination
of effects of the disease's genetic
mutation and the recombination -
related genetic modifications (often random).
Using young and aged transgenic mice and human - derived induced pluripotent stem cells, she will examine the
effect of Alzheimer's -
related mutations on translation and protein expression.
This is in accordance with previous reports that decitabine and 5 - azacytidine produce a marked synergistic
effect in combination with suberoylanilide hydroxamic acid and romidepsin in T - lymphoma cell lines by modulating cell cycle arrest and apoptosis.26, 27 As a mechanism
of action, KMT2D
mutations of B - lymphoma cells promote malignant outgrowth by perturbing methylation
of H3K4 that affect the JAK - STAT, Toll - like receptor, or B - cell receptor pathway.28, 29 Here our study indicated that dual treatment with chidamide and decitabine enhanced the interaction
of KMT2D with the transcription factor PU.1, thereby inactivating the H3K4me - associated signaling pathway MAPK, which is constitutively activated in T - cell lymphoma.13, 30,31 The transcription factor PU.1 is involved in the development
of all hematopoietic lineages32 and regulates lymphoid cell growth and transformation.33 Aberrant PU.1 expression promotes acute myeloid leukemia and is
related to the pathogenesis
of multiple myeloma via the MAPK pathway.34, 35 On the other hand, PU.1 is also shown to interact with chromatin remodeler and DNA methyltransferease to control hematopoiesis and suppress leukemia.36 Our data thus suggested that the combined action
of chidamide and decitabine may interfere with the differentiation and / or viability
of PTCL - NOS through a PU.1 - dependent gene expression program.